Heplisav-B Vaccine for Hep B Finally Wins FDA Approval
Rejected twice before by the agency, the new vaccine must undergo a large postmarketing study on the risk for acute myocardial infarctions and immune-mediated diseases. FDA Approvals …read more
Rejected twice before by the agency, the new vaccine must undergo a large postmarketing study on the risk for acute myocardial infarctions and immune-mediated diseases. FDA Approvals …read more
The EMA’s Committee for Medicinal Products for Human Use has recommended marketing authorization for prasterone for the treatment of postmenopausal women with vulvar and vaginal atrophy. International Approvals …read more
Women and their doctors should weigh risks to the fetus from the medications against those associated with severe, untreated ADHD, experts cautioned. Medscape Medical News …read more